A Trial of Radiotherapy and Durvalumab in DLBCL and FL

Clinical trial NCT03610061 · COMPLETED

Trial details

NCT number: NCT03610061
Sponsor: Austin Health
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma Follicular Lymphoma

Start date: 2018-11-01
Primary completion: 2023-04-05
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.